http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102012010244-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
filingDate 2012-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fcb742e4a489bd59b7257834afd3c6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3333b346a6a1d49d19d6f6de8263933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc5fdb123bea635f522746d59b87354b
publicationDate 2013-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-102012010244-A2
titleOfInvention combination of 4- {3- [cis-hexahydro-cyclopenta [c] pyrrol-2 (1h) -yl] propoxy} benzamide and an acetylcholine esterase inhibitor, and pharmaceutical compositions containing the same
abstract ASSOCIATION BETWEEN 4- {3-CIS-HEXA-HYDROCYCLOPENTA [C] PIRROL-2 (1H) -IL] PROPĂ  XI} BENZAMIDE AND AN ACETILCO-LINAESTERASE INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. The present invention relates to the combination of 4- {3- [cis-hexahydro-cyclopenta [c] pyrrol-2 (1H) -yl] propoxy} benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, and an acetylcholinesterase inhibitor. The invention further relates to medicaments.
priorityDate 2011-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263804
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ86GC8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457834382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77991
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ92035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3152
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21836
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO62763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10100
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB4FZ87
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428318753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29499
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22303
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454091746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70941112
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36196
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559212
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07692
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP56161
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11423
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ92081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ867X3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID489828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ867X2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114549
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID113580815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505226
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83817
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9DDE3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414100136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ869C3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP37136
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3667129
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO42275
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7LZG1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5G2QVL5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAA68151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570570
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ86GC9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540446

Total number of triples: 87.